Marimastat: the clinical development of a matrix metalloproteinase inhibitor (Q34090996)

30 July 2017

1 reference

title

Marimastat: the clinical development of a matrix metalloproteinase inhibitor (English)

1 reference

30 July 2017

Steward WP

1

1 reference

30 July 2017

Thomas AL

series ordinal

2

1 reference

30 July 2017

language of work or name

English

0 references

publication date

1 December 2000

1 reference

Expert Opinion on Investigational Drugs

30 July 2017

published in

1 reference

30 July 2017

volume

9

1 reference

30 July 2017

issue

12

1 reference

30 July 2017

page(s)

2913-2922

1 reference

Changing views of the role of matrix metalloproteinases in metastasis

30 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.12.2913

Matrix metalloproteinase inhibitors in the treatment of cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.12.2913

The stromal proteinase MMP3/stromelysin-1 promotes mammary carcinogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.12.2913

Conversion of highly malignant colon cancer from an aggressive to a controlled disease by oral administration of a metalloproteinase inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.12.2913

Therapeutic effect of the matrix metalloproteinase inhibitor, batimastat, in a human colorectal cancer ascites model

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.12.2913

Matrix metalloproteinase inhibition attenuates human pancreatic cancer growth in vitro and decreases mortality and tumorigenesis in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.12.2913

Synthetic matrix metalloproteinase inhibitor, BB-94, inhibits the invasion of neoplastic human prostate cells in a mouse model

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.12.2913

Requirement for specific proteases in cancer cell intravasation as revealed by a novel semiquantitative PCR-based assay.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.12.2913

Results of single and repeat dose studies of the oral matrix metalloproteinase inhibitor marimastat in healthy male volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.12.2913

10.1517/13543784.9.12.2913

21 January 2018

Identifiers

DOI

1 reference

30 July 2017

1 reference